NDC 43598-129-01 - METHYLPREDNISOLONE SODIUM SUCCINATE

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 43598-129
Requested NDC: 43598-129-01
Package NDCs from labels: 43598-129-01, 43598-129-25
Manufacturer: HF Acquisition Co LLC, DBA HealthFirst
Effective date: 2026-07-24
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
METHYLPREDNISOLONE SODIUM SUCCINATE - HF Acquisition Co LLC, DBA HealthFirst	HF Acquisition Co LLC, DBA HealthFirst	2026-07-24	HUMAN PRESCRIPTION DRUG LABEL
Methylprednisolone sodium succinate - REMEDYREPACK INC.	REMEDYREPACK INC.	2026-04-15	HUMAN PRESCRIPTION DRUG LABEL
Methylprednisolone sodium succinate - Dr. Reddy's Laboratories Inc \| Tianjin Kingyork Pharmaceuticals Co., Ltd	Dr. Reddy's Laboratories Inc \| Tianjin Kingyork Pharmaceuticals Co., Ltd	2024-06-17	HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
43598-129-01	Methylprednisolone sodium succinate	2 mL in 1 VIAL, SINGLE-DOSE	INJECTION	2		4
43598-129-25	Methylprednisolone sodium succinate	25 in 1 CARTON	INJECTION	25		4

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
43598-129	METHYLPREDNISOLONE SODIUM SUCCINATE INJECTION [DR. REDDY'S LABORATORIES INC]	4	Current NDC, Legacy NDC, 2 package rows	20240619_738753c7-507d-4881-5194-02dd7597768b.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
43598-129-01	EA - Each	43598-129	84266e20-5f6c-4b2c-a1df-732f9655f020	1	2022-07-06
43598-129-25	EA - Each	43598-129	07944302-bc2c-49ea-9e59-7a0b4e5d211c	1	2022-04-06

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 4 of 4 · 80 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
NAT. PHOS.	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	Hyland's Inc.	9ad86f9f-df9e-4e5c-bce4-571e1da44145	2022-12-19	Warnings	Exact identifier unii: 22ADO53M6F
Anticoagulant Citrate Phosphate Dextrose (CPD) Blood-Pack Units in PL 146 Plastic	ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION	Fenwal, Inc.	d55cb701-9664-4931-8754-1a8cae68da06	2022-11-01		Exact identifier unii: 593YOG76RN
CPDA-1	ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE (CPDA-1) SOLUTION	Fenwal, Inc.	f9d7f1b4-7a77-44f9-8924-10b16008b49d	2022-11-01		Exact identifier unii: 593YOG76RN
Anticoagulant Citrate Phosphate Dextrose (CPD) Blood-Pack Units in PL 146 Plastic	ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD)	Fenwal, Inc.	4a08a9ec-46a5-4fcf-80ee-5c33f1a8b746	2022-11-01		Exact identifier unii: 593YOG76RN
Sodium Phosphates	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE AND SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	Fresenius Kabi USA, LLC	5bf47be3-f3fe-452b-8113-941796498345	2022-03-31	Warnings, Adverse reactions	Exact identifier unii: 22ADO53M6F unii: 593YOG76RN
CPDA-1	ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE	Fenwal, Inc.	d763511e-f1a7-4014-94b9-f7ad8f023ff4	2021-12-02		Exact identifier unii: 593YOG76RN
CPDA-1	ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE	Fenwal, Inc.	cf9f43a0-c750-4cf0-ac49-176ab2105aab	2021-12-02		Exact identifier unii: 593YOG76RN
InterSol	PLATELET ADDITIVE 3	Fenwal, Inc.	e4f06c0b-7cb1-49c9-97a4-2cfc21298495	2021-11-16	Warnings, Adverse reactions	Exact identifier unii: 593YOG76RN
Solucion InterSol	SOLUCION ADITIVA PARA PLAQUETAS 3	Fenwal, Inc.	d5eaf5f4-67d3-4475-af9a-f5b0f882f5d1	2021-10-04	Warnings, Adverse reactions	Exact identifier unii: 593YOG76RN
Sodium Phosphates	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE	Fresenius Kabi USA, LLC	e6169d3b-39d2-47f9-8d5b-b53ec069a722	2021-07-23	Warnings, Adverse reactions	Exact identifier unii: 22ADO53M6F unii: 593YOG76RN
InterSol	PLATELET ADDITIVE 3	Fenwal, Inc.	a00c4a93-cde2-4753-81f7-0d6fee9fb690	2020-10-20	Warnings, Adverse reactions	Exact identifier unii: 593YOG76RN
CPDA-1	ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE	Fenwal, Inc.	ee831456-5962-4d5e-ad0c-69ab85860453	2020-06-03		Exact identifier unii: 593YOG76RN
CPDA-1	ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE	Fenwal, Inc.	e41adb4e-06fb-4141-ba55-50b043f3c9da	2019-11-19		Exact identifier unii: 593YOG76RN
CPDA-1	ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE	Fenwal, Inc.	14445dfd-6041-40cd-a043-3f4da6bcb9c1	2019-11-18		Exact identifier unii: 593YOG76RN
CPDA-1	ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE	Fenwal, Inc.	2557199a-5f60-49d8-b093-1e0700211243	2019-11-18		Exact identifier unii: 593YOG76RN
CPDA-1	ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE	Fenwal, Inc.	794f724c-87f0-49c1-9b26-c9e491978313	2019-11-18		Exact identifier unii: 593YOG76RN
CPDA-1	ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE	Fenwal, Inc.	5c7d3287-883a-459b-9214-074a583c8a59	2019-11-18		Exact identifier unii: 593YOG76RN
CPDA-1	ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE	Fenwal, Inc.	448a1dc5-7a98-4b2f-82af-4b92de05cfc3	2019-11-18		Exact identifier unii: 593YOG76RN
URELLE	HYOSCYAMINE SULFATE, METHENAMINE, METHYLENE BLUE, PHENYL SALICYLATE, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE	Viatris Specialty LLC	1d80a11c-6f86-403b-85d4-32ec1924dbe9	2015-01-13	Warnings, Adverse reactions	Exact identifier unii: 593YOG76RN
CPDA-1	ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE	Fenwal, Inc.	051f7347-5a76-4664-8fe2-e61b3dfcb0e4	2014-08-27		Exact identifier unii: 593YOG76RN

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.